FMC secures $400m investment from Tessenderlo Group

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

FMC Corporation has secured a $400 million minority equity investment from Tessenderlo Group at $13.30 per share, granting the investor a 20.0% stake. The proceeds will be used to reduce debt by approximately $1 billion, marking the end of FMC's strategic options review. The transaction is subject to regulatory approvals.

powered bylight_fuzz_icon
44420178

*this image is generated using AI for illustrative purposes only.

FMC Corporation has entered into a definitive agreement for Tessenderlo Group to make a strategic minority equity investment of approximately $400 million at a price of $13.30 per share. This transaction will allow Tessenderlo Group to own approximately 20.0% of the outstanding shares of FMC common stock. FMC intends to use the funds to pay down debt, enabling the company to reach its approximately $1 billion debt paydown target and improve its financial flexibility.

The agreement concludes the FMC Board of Directors' exploration of strategic options announced in February 2026. Pierre Brondeau, chairman, chief executive officer and president of FMC, stated that the Board is confident this agreement is the best path forward for the company and its shareholders. The company will continue to execute its operational and strategic plan as an independent entity, focusing on advancing its R&D pipeline and accelerating the commercialization of innovations.

Luc Tack, chief executive officer of Tessenderlo Group, said the investment aligns with the group's strategy to expand its agro platform through cornerstone minority positions in high-quality companies. He cited FMC's long-term potential driven by a new generation of proprietary molecules that are renewing its portfolio.

Strategic and Financial Actions

In addition to the equity investment, FMC has undertaken several measures over recent months to unlock capital and sharpen its strategic focus. These actions include:

  • Amending its Revolving Credit Facility to achieve significant covenant relief.
  • Raising $1.2 billion in a secured high-yield bond offering.
  • Signing an agreement to sell the Company's India commercial business for $252 million.
  • Entering into a strategic supply and license agreement with Corteva, Inc., which includes an initial prepayment of $200 million.
  • Signing a framework agreement for a $114 million sale & leaseback of its Newark, Delaware property.

Transaction Details

Transaction Component Details
Investment Amount Approximately $400 million
Price Per Share $13.30
Ownership Stake Approximately 20.0%
Debt Paydown Target Approximately $1 billion

The closing of the transaction is subject to customary conditions, including the receipt of regulatory approvals. BofA Securities and Goldman Sachs & Co. LLC are serving as financial advisors to FMC Corporation, with Davis Polk & Wardwell LLP as legal counsel. Stibbe BV/SRL and Sullivan & Cromwell LLP are serving as legal advisors to Tessenderlo Group.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the 20% ownership stake by Tessenderlo Group influence FMC's future strategic decision-making and board composition?

What specific R&D projects in the new proprietary molecule pipeline will be prioritized following the debt paydown?

Will FMC pursue further asset sales or divestitures to maintain financial flexibility after the India commercial business sale?

like17
dislike

FMC to sell Newark property for $114M and lease back

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

FMC Corporation agreed to sell its Newark, Delaware property for $114 million and lease back the facilities. The transaction is subject to due diligence and closing conditions.

powered bylight_fuzz_icon
43764525

*this image is generated using AI for illustrative purposes only.

FMC Corporation has entered into a framework agreement to sell its property in Newark, Delaware for approximately $114 million. The agricultural sciences company intends to lease back the facilities it actively operates under a separate lease agreement upon completion of the sale. FMC will retain ownership of its adjacent Maryland properties.

The transaction is subject to a due diligence period and other closing conditions and adjustments. The sale and subsequent leaseback arrangement aim to optimize the company's real estate assets while maintaining operational continuity at the Newark site.

Transaction Details

Aspect Details
Property Location Newark, Delaware
Sale Proceeds ~$114 million
Post-Sale Arrangement Leaseback of operated facilities
Retained Assets Adjacent Maryland properties

The framework agreement marks a strategic move by FMC to unlock value from its real estate holdings. By leasing back the facilities, the company ensures that its active operations in Newark continue without disruption. The deal is expected to close after the due diligence period and satisfaction of other conditions.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How does FMC plan to allocate the approximately $114 million in proceeds from the sale?

What are the specific financial terms and duration of the leaseback agreement?

Could this sale-leaseback strategy signal a broader trend of asset monetization for FMC?

like16
dislike

More News on FMC